- Home
- IMSR vs TKNO Comparison
IMSR vs TKNO Comparison
Compare IMSR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMSR
- TKNO
- Stock Information
- Founded
- IMSR 2013
- TKNO 1996
- Country
- IMSR United States
- TKNO United States
- Employees
- IMSR N/A
- TKNO N/A
- Industry
- IMSR
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- IMSR
- TKNO Health Care
- Exchange
- IMSR Nasdaq
- TKNO Nasdaq
- Market Cap
- IMSR 233.8M
- TKNO 236.6M
- IPO Year
- IMSR N/A
- TKNO 2021
- Fundamental
- Price
- IMSR $8.09
- TKNO $4.62
- Analyst Decision
- IMSR
- TKNO
- Analyst Count
- IMSR 0
- TKNO 0
- Target Price
- IMSR N/A
- TKNO N/A
- AVG Volume (30 Days)
- IMSR 1.8M
- TKNO 193.5K
- Earning Date
- IMSR 01-01-0001
- TKNO 11-06-2025
- Dividend Yield
- IMSR N/A
- TKNO N/A
- EPS Growth
- IMSR N/A
- TKNO N/A
- EPS
- IMSR N/A
- TKNO N/A
- Revenue
- IMSR $123,320.00
- TKNO $39,801,000.00
- Revenue This Year
- IMSR N/A
- TKNO $9.52
- Revenue Next Year
- IMSR N/A
- TKNO $15.20
- P/E Ratio
- IMSR N/A
- TKNO N/A
- Revenue Growth
- IMSR 1234.25
- TKNO 9.50
- 52 Week Low
- IMSR $8.65
- TKNO $3.94
- 52 Week High
- IMSR $31.50
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- IMSR N/A
- TKNO 47.31
- Support Level
- IMSR N/A
- TKNO $4.25
- Resistance Level
- IMSR N/A
- TKNO $4.79
- Average True Range (ATR)
- IMSR 0.00
- TKNO 0.36
- MACD
- IMSR 0.00
- TKNO 0.01
- Stochastic Oscillator
- IMSR 0.00
- TKNO 57.78
About IMSR Terrestrial Energy Inc. Common Stock
Terrestrial Energy Inc is an industry-leading technology company committed to delivering reliable, emission-free, and cost-competitive nuclear energy with a transformative advanced reactor, the Integral Molten Salt Reactor (IMSR). Its mission is to transform global energy markets by commercializing its IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.